Patients aged 50-59 with one chronic condition are now eligible for the COVID-19 antiviral nirmatrelvir–ritonavir (Paxlovid) under the PBS. The PBAC recommended the expanded criteria…
A “reckless” pharmacist has been banned for five years, nearly a decade after he defrauded the PBS of $42,000 by submitting fake claims for fertility…
An impending ban on GPs administering long-acting buprenorphine as a private script will risk vulnerable patients falling through the cracks, says GP and addiction expert…
The meningococcal B vaccination catch-up program for Indigenous children should become a permanent fixture on the NIP, the PBAC has recommended. Since 2020, the National Immunisation Program (NIP)…
Patients paying $150 a month for opioid dependence treatment will see their out-of-pocket costs slashed to $30 a month under major PBS changes, the RACGP says.…
The RACGP has rejected calls for the PBS listing for initiating GLP-1 receptor agonists to move to authority required amid concerns it will add to…
Much ink and even tears were spilled over the Federal Government’s plan for 60-day dispensing, but the impact on pharmacies and patients depends on a…
The Federal Government is boosting rebates for nurse practitioners by 30% and removing the requirement they must work with a doctor to access the MBS…
Two weeks ago, the president of the Pharmacy Guild of Australia stood before reporters on the verge of tears as he accused the federal Minister…
GPs will be allowed to prescribe subsidised Flixotide Junior and Axotide Junior to young children once more after the PBAC partly reversed its controversial changes. It means initial scripts for fluticasone…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
